Latest News

New compound to treat depression identified

A compound, hydroxynorketamine (HNK), has been identified by researchers that may treat symptoms of depression just as effectively and rapidly as ketamine, without the unwanted side effects associated with the psychoactive drug, according to a study. Interestingly, use of HNK may also serve as a future therapeutic approach for treating neurodegenerative disorders such as Alzheimer's and Parkinson's diseases, the authors note.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Quitting cigarettes tougher for heavy-drinking smokers, but phone counseling can help

  • Suicide risk falls substantially after talk therapy

  • Breakthrough discovery contributes to future treatment of multiple sclerosis, autoimmune inflammation

  • Motor coordination issues in autism are caused by abnormal neural connections

  • Schizophrenia may be triggered by excess protein during brain development

  • The sound of status: People know high-power voices when they hear them

  • Neurodegenerative diseases: Has a possible new lead been found?

  • Declining loneliness among American teenagers

  • Protein that rouses brain from sleep may be target for Alzheimer's prevention

  • Does dip decrease or deepen addiction to nicotine?

  •